Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Autor: El-Shenawy R; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Moustafa RI; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.; School of Pharmacy, Newgiza University (NGU), Newgiza, 12577, Giza, Egypt., Helmy NM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., El-Abd YS; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Tabll AA; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt.; Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt., Elesnawy YK; National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt., Shawky H; Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt. hs.tohami@nrc.sci.eg.

Publikováno v: Virology journal [Virol J] 2024 Nov 15; Vol. 21 (1), pp. 293. Date of Electronic Publication: 2024 Nov 15.

Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Autor: Shawky H; Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Tabll AA; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Elshenawy RM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Helmy NM; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Moustafa RI; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt., Elesnawy YK; Ahmed Maher Teaching Hospital, Cairo, Egypt., Abdelghany MM; National Committee for Control of Viral Hepatitis (NCCVH), Ministry of Health and Population, Cairo, Egypt., El-Abd YS; Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Cairo, 12622, Egypt. ys.el-abd@nrc.sci.eg.

Publikováno v: Microbial cell factories [Microb Cell Fact] 2024 Jan 18; Vol. 23 (1), pp. 25. Date of Electronic Publication: 2024 Jan 18.

Low Molecular Mass Polypeptide 7 Single Nucleotide Polymorphism is Associated with the Progression of Liver Fibrosis in Patients Infected with Hepatitis C Virus Genotype 4

Autor: El Abd Ys, Abdel Aziz Ao, Abdel Aziz Ms, Moataza H Omran, El Shenawy R, Elsharkawy A, Reham M. Dawood, El Awady Mk, Bader El Din Ng, Moustafa Am, Marwa K. Ibrahim

Publikováno v: Clinical Laboratory. 62

BACKGROUND The hepatitis C virus (HCV) is a leading cause of liver disease and the consequent complications of cirrhosis. However, there is no precise biomarker to predict the patients at high risk of developing progressive disease. We showed previou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b20522b4f85e10c13c1e275a39ee1e
https://doi.org/10.7754/clin.lab.2015.150710

Importance of Studying the Levels of Hepcidin and Vitamin D in Egyptian Children with Chronic Hepatitis C.

Autor: Mohamed AA; Biochemistry and Molecular Biology, Biochemistry Department, National Hepatology and Tropical Centre, Cairo, Egypt., Abd Almonaem ER; Department of Pediatrics, Faculty of Medicine, Benha University, Benha, Egypt., Mansour AI; Department of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Benha, Egypt., Algebaly HF; Department of Pediatrics, Pediatric and Pediatric Intensive Care, Cairo University School of Medicine, Cairo, Egypt., Khattab RA; Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt., El Abd YS; Department of Microbial Biotechnology, Genetic Engineering and Biotechnology Division, National Research Centre, Cairo, Egypt.

Publikováno v: Journal of translational internal medicine [J Transl Int Med] 2019 Mar 29; Vol. 7 (1), pp. 15-21. Date of Electronic Publication: 2019 Mar 29 (Print Publication: 2019).

Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors.

Autor: Galal SA; Department of Chemistry of Natural and Microbial Products, Division of Pharmaceutical and Drug Industries, National Research Centre, Cairo, 12622, Egypt. Electronic address: sh12galal@hotmail.com., Khairat SHM; Department of Chemistry of Natural and Microbial Products, Division of Pharmaceutical and Drug Industries, National Research Centre, Cairo, 12622, Egypt., Ali HI; Department of Pharmaceutical Sciences, Texas A&M University Irma Lerma Rangel College of Pharmacy Kingsville, TX 78363, United States; Department of Pharmaceutical Chemistry, College of Pharmacy, Helwan University, Cairo, Egypt., Shouman SA; Department of Cancer Biology, National Cancer Institute, Cairo University, Egypt., Attia YM; Department of Cancer Biology, National Cancer Institute, Cairo University, Egypt., Ali MM; Department of Biochemistry, Division of Genetic Engineering and Biotechnology, National Research Centre, 12622, Cairo, Egypt., Mahmoud AE; Department of Biochemistry, Division of Genetic Engineering and Biotechnology, National Research Centre, 12622, Cairo, Egypt., Abdel-Halim AH; Department of Biochemistry, Division of Genetic Engineering and Biotechnology, National Research Centre, 12622, Cairo, Egypt., Fyiad AA; Department of Biochemistry, Division of Genetic Engineering and Biotechnology, National Research Centre, 12622, Cairo, Egypt., Tabll A; Department of Microbial Biotechnology, Division of Genetic Engineering & Biotechnology, National Research Centre, 12622, Cairo, Egypt., El-Shenawy R; Department of Microbial Biotechnology, Division of Genetic Engineering & Biotechnology, National Research Centre, 12622, Cairo, Egypt., El Abd YS; Department of Microbial Biotechnology, Division of Genetic Engineering & Biotechnology, National Research Centre, 12622, Cairo, Egypt., Ramdan R; Radiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Mol, Belgium; Department of Basic Medical Sciences, Physiology Group, Ghent University, Ghent, Belgium., El Diwani HI; Department of Chemistry of Natural and Microbial Products, Division of Pharmaceutical and Drug Industries, National Research Centre, Cairo, 12622, Egypt.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2018 Jan 20; Vol. 144, pp. 859-873. Date of Electronic Publication: 2017 Dec 08.